Article metrics

Extended report
MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial

 

Online download statistics by month:

Online download statistics by month: February 2014 to October 2022

AbstractFullPdf
Feb 2014519111162
Mar 2014157129102
Apr 2014728473
May 2014446053
Jun 2014345740
Jul 2014606050
Aug 2014413934
Sep 2014327546
Oct 2014406341
Nov 2014343328
Dec 2014393620
Jan 2015534635
Feb 2015384536
Mar 2015655838
Apr 2015375435
May 20151045113205
Jun 20154716271
Jul 20151896945
Aug 20151534239
Sep 20151614433
Oct 2015833621
Nov 2015874533
Dec 2015794224
Jan 2016815050
Feb 2016973221
Mar 2016502626
Apr 2016793630
May 2016812526
Jun 2016393239
Jul 2016632924
Aug 2016621824
Sep 2016733020
Oct 2016613517
Nov 2016433129
Dec 201626155
Jan 2017514316
Feb 2017174622
Mar 201754818
Apr 201777319
May 201755836
Jun 2017295851
Jul 2017625340
Aug 201714613044
Sep 20171097224
Oct 20171268630
Nov 201721217436
Dec 201729725640
Jan 201826824661
Feb 201820217734
Mar 201822817634
Apr 201814111939
May 201814110423
Jun 20181048416
Jul 201812410024
Aug 20181139516
Sep 2018857113
Oct 201814311744
Nov 20181261148
Dec 20181028014
Jan 201917615824
Feb 20191058017
Mar 2019706026
Apr 2019524615
May 2019523913
Jun 201959459
Jul 2019686319
Aug 2019746819
Sep 2019412611
Oct 2019615515
Nov 2019615313
Dec 2019403817
Jan 2020726631
Feb 2020645624
Mar 2020504622
Apr 2020372915
May 2020383426
Jun 2020554720
Jul 2020453315
Aug 2020372913
Sep 2020724511
Oct 20201045517
Nov 202036279
Dec 202041317
Jan 202146408
Feb 2021363419
Mar 2021514511
Apr 2021413812
May 2021424015
Jun 2021575713
Jul 2021323210
Aug 2021323114
Sep 2021404012
Oct 2021777713
Nov 2021666021
Dec 202145439
Jan 202211510620
Feb 2022606017
Mar 2022665716
Apr 2022757410
May 2022727118
Jun 2022576016
Jul 2022574913
Aug 2022535443
Sep 202261546
Oct 2022646415
Total988667573016